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ABSTRACT 
 Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder. Afflicted 
patients show extreme sun-sensitivity and skin cancer predisposition. XP is in most cases 
associated with deficient nucleotide excision repair (NER), which is the process responsible for 
removing photolesions from DNA. Measuring NER activity by nucleotide incorporation into 
repair patches, termed 'unscheduled DNA synthesis (UDS)', is one of the most commonly used 
assays for XP-diagnosis and NER research. We have established a rapid and accurate 
procedure for measuring UDS by replacement of thymidine with 5-ethynyl-2'-deoxyuridine 
(EdU). EdU incorporated into repair patches can be directly conjugated to fluorescent azide 
derivatives, thereby obviating the need for either radiolabelled thymidine or denaturation and 
antibody detection of incorporated bromodeoxyuridine (BrdU). We demonstrate that the EdU 
incorporation assay is compatible with conventional techniques such as immunofluorescent 
staining and labeling of cells with micro-latex beads. Importantly, we can complete the entire 
UDS assay within half a day from preparation of the assay coverslips; this technique provides a 
rapid and convenient non-radioactive UDS assay for XP-diagnosis and NER related research.  
  
 
INTRODUCTION 
 Cells are continuously exposed to various types of DNA damage induced by both 
endogenous and exogenous sources. Consequently, all living organisms have developed DNA 
repair mechanisms to ensure that the integrity of the genetic information is maintained (1). 
Nucleotide excision repair (NER) is one of the most versatile DNA repair systems, which deals 
with the major UV photoproducts, as well as many DNA adducts arising from exposure to a 
variety of chemical carcinogens (2,3). NER involves removal of damaged nucleotides from the 
DNA by dual incisions, and filling and sealing of the residual single strand gaps by DNA 
polymerases and ligases (1-3). 
 Xeroderma pigmentosum (XP) is the prototype NER deficient genetic disorder (2-4), the 
incidence of which is 1 in 80,000 to 1,000,000 in the general population, depending on the 
location (5). XP patients suffer from severe photosensitivity, a high incidence of sunlight-
induced skin cancer, and in some cases neurological abnormalities. In ~80% of XP cases, the 
patients have a defect in one of the genes responsible for NER. XP-variant patients, who 
comprise the residual 20% of XP cases, are proficient in NER but have a defect in post-
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replication repair (PRR) as they lack the specialised DNA polymerase, polη, which accurately 
replicates past cyclobutane pyrimidine dimers (CPDs) (6). 
 Cockayne Syndrome (CS) and Trichothiodystrophy (TTD) are also NER-deficient disorders 
(4,7,8). NER consists of two sub-pathways: global genome repair (GGR) is relatively slow but 
functions genome-wide (3), whereas transcription coupled repair (TCR) is a faster process that 
is specialised for the transcribed strand of actively transcribed regions (9,10). With the 
exception of XPC and XPE, which are used exclusively in GGR (3), all genes defective in 
patients with XP, the combined features of XP and CS (XP/CS), and TTD are associated with 
both pathways, whereas in CS only TCR is compromised (7,9-11). NER-deficient patients have 
been so far assigned to at least eleven complementation groups (XP-A, to G, CS-A, and B, 
TTD-A, and ERCC1), which correspond to 11 different NER damage recognition and incision 
proteins (3,4).  
 
 The most commonly used assay for assessing NER-deficiency entails measuring nucleotide 
incorporation levels associated with DNA repair activity. GGR, which contributes to ~90% of 
NER activity, is assessed by damage induced non-S phase gap-filling DNA replication, termed 
'unscheduled DNA synthesis (UDS)' (12), while TCR activity can be measured by 'recovery of 
RNA synthesis (RRS)' levels after DNA damaging treatment (13).  Currently, a variety of 
methods for measuring UDS have been established (8,12,14-17). 254nm UVC-irradiation is 
commonly used for inducing DNA damage, and cells are then incubated in the presence of 
either radiolabelled thymidine or a nucleoside analog. The most frequently used methods in 
XP-diagnostic laboratories are: [1] 
3
H-thymidine incorporation, followed by evaluation of 
grain counting after autoradiography of tissue-culture coverslips: this technique is accurate and 
compatible with most immunostaining based methods, but the procedures are labor-intensive 
and time-consuming (15,16). [2] Bromodeoxyuridine (BrdU) incorporation, followed by 
alkaline denaturation of DNA, and immunofluorescent detection by anti-BrdU antibody: this is 
a convenient variant of method [1]; replacement of 
3
H-thymidine by BrdU diminishes the time 
needed for the assay, however it has reduced sensitivity (~50% reduction of UDS activity is 
not detectable)(18). [3] Liquid scintillation counting of 
3
H-thymidine incorporation into repair 
patches: although this method is rapid, the quantitative capacity is lower than the other 
methods as this is a batch assay. Furthermore, replicative DNA synthesis has to be abolished 
by using non-dividing cells and the DNA replication inhibitor, hydroxyurea (HU), during the 
assay (12). 
 
 In this report, we have employed 5-ethynyl-2'-deoxyuridine (EdU), an alkyne 
conjugated nucleoside analogue of thymidine, as an alternative to radioactive thymidine or 
BrdU (19). In contrast to the BrdU based UDS assay, EdU can be directly conjugated to 
fluorescent azide (20), and thus, the assay does not require denaturing of DNA nor the use of 
antibodies. We have successfully improved the sensitivity, which is one of the weak points of 
BrdU based methods. Furthermore, the total time for the assay was dramatically reduced even 
compared to the BrdU based assay. Using this technique, a standard UDS assay can be 
completed within half a day from preparation of the assay coverslips. 
 
 
MATERIALS AND METHODS 
Cell strains and cultures 
 All the cells used in this report are human primary fibroblasts. Normal 1BR (21), 48BR 
(21), 142BR (22), and 251BR (22), XP-patient-derived XP12BR (XP-D) (this study), XP15BR 
(XP-A) (22), XP13BR (XP-C) (this study) and XP20BE (XP-G) (23), and CS-patient-derived 
CS10LO (CS-B) (24) cells were used. Cells were cultured in Dulbecco's Modified Eagle 
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Medium (DMEM) supplemented with 10% FBS (Gibco-BRL) and penicillin-streptomycin 
(Wako), and maintained at semiconfluent density during the experiments unless otherwise 
stated. For labeling with latex-beads, 48BR cells were cultured with a few drops of 0.5 µm 
diameter polybead Hydroxylate (Polysciences) in DMEM for 3 days.  
 
UV-induced UDS measurement in normal primary human fibroblasts by Ethynyl deoxyuridine 
(EdU) incorporation 
  5-ethynyl-2'-deoxyuridine (EdU) is available from Invitrogen (19). To optimize UV-
induced UDS by EdU incorporation, effects of UV-dose and EdU incubation period were 
examined. 48BR cells were cultured on coverslips and maintained at confluent density.  Cells 
were washed with PBS, followed by irradiation with different doses (5-20 J/m
2
) of UVC 
(254nm). After UV-irradiation, cells were immediately incubated with serum free DMEM 
supplemented with 10 µM EdU for different periods (0.5, 1, 2, and 4 h). Serum-free medium 
was used since serum often contains thymidine, which competes with EdU for incorporation 
into DNA. Cells were then washed with PBS, followed by fixation and permeabilisation with 
PBS containing 2% formaldehyde, 0.5% triton X-100, and 300 mM sucrose for 20 minutes. 
After extensive washing with PBS, cells were blocked with 10% FBS in PBS for 30 minutes. 
Incorporated EdU was detected by fluorescent-azide coupling reaction (Click-iT, Invitrogen) 
(19). Briefly, cells were incubated for 30min with azide-conjugated Alexa Fluor-488 dye in 
TBS supplemented with 4mM CuSO4. Cells were then washed 3 times with PBS containing 
0.05% Tween20 (PBST). Coverslips were finally soaked with PBS, fixed with 3.7% 
formaldehyde in PBS for 20min, and mounted on glass slides with Aquapolymount
 
(Polysciences). Photographs of the cells were captured with a fluorescent microscope equipped 
with a CCD camera (BIOREVO9000-KEYENCE), and captured images were processed and 
analysed with ImageJ software (NIH). At least 50 non-S-phase cells were randomly selected 
from a single captured field, and the average nuclear fluorescent intensity was calculated. Data 
points presented in the text are the averages calculated from five different fields. 
 We found that 20J/m
2
 UV-irradiation followed by 2 h EdU incubation was the optimal 
condition for the UDS assay. This condition was us d for all experiments except for Figure 1A. 
 
BrdU incorporation assay 
 Cells were cultured and UVC irradiated (20J/m
2
), and incubated in conditions identical 
to the EdU incorporation assay described above (5µM BrdU, instead of EdU, was 
supplemented). Cells were then washed with PBS, followed by fixation and permeabilisation in 
PBS containing 2% formaldehyde, 0.5% tritonX-100, and 300 mM sucrose for 20 min. After 
extensive washing with PBS, cells were treated with 4 M HCl in PBS for 15 min for denaturing 
DNA. Cells were extensively washed with PBS for neutralisation, followed by blocking with 
10% FBS in PBS for 30 min. Incorporated BrdU was detected by 1 h incubation with mouse 
anti-BrdU antibody (BD, diluted 1:150 in PBST). Cells were then washed 3 times with PBST, 
followed by 1 h incubation with Alexa Fluor-488 conjugated goat anti-mouse IgG (Invitrogen, 
diluted 1:500 in PBST). Coverslips were finally soaked in PBS, fixed with 3.7% formaldehyde 
in PBS for 20 min, and mounted on glass slides with Aquapolymount
 
(Polysciences). Image 
capture and analyses were performed as described above. 
 
3
H-thymidine incorporation assay 
 Details of the assay have been previously described (12). Cells were cultured in 1% 
DMEM for three days (3×10
5
 cells per 5cm-diameter dish). They were then incubated for 1h 
with 10mM hydroxyurea (HU), UV irradiated and incubated for a further 3h with 1% DMEM 
containing 10µCi/ml 
3
H-thymidine and 10 mM HU. Incorporated 
3
H-thymidine incorporated 
into acid-insoluble materials was measured by liquid scintillation counting. 
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Immunostaining 
 48BR and XP20BE cells were mix-cultured at 1:1 ratio (48BR alone for ki67 staining). 
UV-irradiation, EdU incubation, and fixing and permeabilisation steps were as described above. 
For antibody detection, cells were blocked with 10% FBS in PBS for 30 min, followed by 1 h 
incubation with mouse monoclonal anti-XPG (8H7, Santa Cruz Biotechnology), or rabbit 
monoclonal anti-ki67 (SP6, Thermo scientific) antibodies (diluted 1: 100 in PBST). Cells were 
then washed 3 times with PBST, followed by 1 h incubation with secondary antibodies: Alexa 
Fluor-594 conjugated goat-anti-mouse-, and goat-anti-rabbit-IgG, for XPG and ki67 detection, 
respectively (Invitrogen, diluted 1:1000 in PBST). To avoid unnecessary nuclear fluorescence, 
DAPI staining was omitted. After extensive washing with PBST, cells were fixed for 20 min 
with 3.7% formaldehyde in PBS. Subsequently, EdU detection was carried out as described 
above. 
 
 
RESULTS 
Effects of UV-dose and EdU-incubation period on measurement of UV-induced UDS in 
normal human primary fibroblasts 
 48BR normal primary human fibroblasts were cultured on coverslips and subsequently 
exposed to different doses of UVC, followed by incorporation of EdU for different time 
periods. UVC treatment elicited UDS activity as shown by an increase in nuclear fluorescence, 
after conjugation of fluorescent azide to incorporated EdU (Figures 1A, 1B).  As reported in 
previous publications employing 
3
H-thymidine labeling and autoradiography (15,16), strong 
signals from scheduled DNA synthesis in S-phase cells can be distinguished from much 
weaker cell-cycle independent unscheduled EdU incorporation, resulting from repair synthesis 
(Figure 1B). Additionally, the fluorescent-azide coupling reaction seems specific to 
incorporated EdU, as we barely detected any non-specific cytoplasmic staining or DNA 
replication independent nuclear signals (Figure 1B). We observed that the nuclear fluorescent 
intensities were proportional to both UV dose and EdU incubation time, indicating that this 
endpoint satisfactorily represents the amount of incorporated EdU, which is directly 
convertible to semiquantitative UDS measurement (Figure 1A). We were able to detect nuclear 
fluorescent signals at relatively low UV exposures, and with short time-periods of post UV 
EdU incubation, demonstrating that this technique is sensitive enough to detect low levels of 
UDS activity. 
  
Sensitivity and resolution of the EdU based UDS assay 
 We evaluated the resolution as well as the sensitivity of the EdU based UDS assay, by 
comparing the results obtained from the EdU technique with that of conventional 
autoradiography and BrdU based methods. Many publications that have utilized 
autoradiography for the UDS assay report UDS levels for the most severe XP-cases (i.e. XP-A, 
or XP-G/CS) as <5~10% of normal levels (25). These can be distinguished from cell strains 
from XP patients, typically from XP-C or XP-D groups, that often have UDS levels of 20~40% 
of residual UDS activity (intermediate UDS level). The intensity distribution plots for the EdU 
based UDS assay for both normal 48BR (UDS positive, Figure 1C) and XP-deficient XP15BR 
(UDS negative, Figure 1D) fibroblasts resemble to those of published autoradiography based 
experiments, though we acknowledge that the background UDS levels were relatively higher 
than that from autoradiography; this point is discussed later. The EdU assay consistently 
produced a satisfactory S.D. of 10~15%. 
 We compared the relative sensitivities of the EdU assay and the anti-BrdU based method. 
Though BrdU has been commonly used for S-phase labeling, publications using it for UDS 
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assays are quite limited because of its restricted sensitivity and resolution (18). (Figures 1E, 
1F). Although the histograms of normal 48BR and XP-deficient XP15BR fibroblasts could be 
discriminated by the BrdU based assay (Figures 1E, 1F), the resolution as well as S.D. were 
both markedly improved in the EdU method, suggesting that EdU is a more sensitive substitute 
for BrdU in the UDS assay.  
 
UV-induced EdU incorporation in NER-deficient primary fibroblasts 
 To apply the EdU technique to XP diagnosis, we estimated the levels of UV-induced 
EdU incorporation in several NER-deficient primary fibroblasts as well as normal controls 
(Figures 2A-2G for histograms, and 2I for typical photos). Since XP is a genetically 
heterogenous disorder, both the NER genes affected and the types of mutations determine the 
magnitude of the defect in UDS. We measured UDS in XP15BR (XP-A), XP20BE (XP-G/CS), 
XP13BR (XP-C), XP12BR (XP-D), and CS-patient-derived CS10LO (CS-B) cells, and 
compared the results with those obtained using 
3
H thymidine incorporation.  With 20J/m
2
 UVC 
irradiation, we observed substantial UDS in normal fibroblasts, 48BR (Figure 2A) and 1BR 
(Figure 2B), as measured by EdU incorporation. We barely detected any UDS in severe XP-
patient-derived XP15BR (XP-A, Figure 2C) and XP20BE (XP-G, Figure 2D) fibroblasts, while 
we detected marginal (~20% of normal) UDS activity in XP-C patient-derived XP13BR 
(Figure 2E) fibroblasts. 
 XP12BR is homozygous for R511Q mutation in the XPD gene (our unpublished data), and, as 
shown in Figure 2F, we found approx. 40% of normal UDS activity. In Figure 2H, we show the 
data obtained with the same set of cell strains using the 
3
H thymidine incorporation. In good 
agreement with the EdU assay, UDS was barely detectable in XP15BR, but were about ~20% 
and ~40% of normal in XP13BR and XP12BR, respectively. These results show good 
agreement between the two methods and demonstrate that cells exhibiting intermediate UDS 
activity can be distinguished from both normal and severe UDS defects by the EdU based 
assay. 
 We then further examined whether CS-deficient fibroblasts were distinguishable from normal 
cell-lines by the UDS assay. CS is only compromised in the TCR pathway of NER, and this is 
not precisely diagnosed by UDS assays, since the deficiency is usually subtle. Though Figure 
2G indicates a modest (~20%) reduction of the UDS level compared to the normal fibroblasts, 
we can't conclude this to be significant and is likely to fall within the normal range.  
 Levels of nuclear fluorescence after UVC irradiation in sev re NER-deficient fibroblasts 
(Figures 2C, 2D) were virtually the same as those in unirradiated samples, suggesting that the 
background fluorescent signals resulting from minor EdU incorporation or non-specific 
fluorescent conjugation do not affect the analyses. We conclude that the EdU based UDS assay 
provides a specific measurement of nucleotide incorporation associated with the repair 
synthesis step of NER. 
 
Compatibilities of the EdU based UDS assay with other techniques 
  We anticipate applying the EdU based UDS assay system to clinical diagnoses, in 
which rigorous intra-assay controls are required. We therefore assessed the compatibility of the 
UDS assay with other standard techniques that use internal references. We found that 
fluorescent-azide conjugation to EdU is fully compatible with immunofluorescent staining 
(Figures 3A, 3B). 
 Co-culture of an index fibroblast as well as a target under study on the same coverslip 
provides a rigorous internal control. In Figure 3A, normal and XPG-deficient fibroblasts were 
co-cultured, followed by UV-UDS assayed in combination with α-XPG immunostaining. EdU 
positive cells (excluding S-phase) perfectly correspond to XPG positive cells, indicating that 
two different cell populations can be distinguished in the UDS assay. 
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 Similarly, we examined if there was a cell-cycle preference for the EdU assay: co-
immunostaining with a proliferation marker, ki-67, demonstrated that UDS can be detected in 
quiescent fibroblasts (no Ki67 stain) as well as proliferating populations (Figure 3B). 
 
 As discussed above, the level of the defect in UDS activity varies between different XP 
patients. Ideally, ascertaining whether a patient is NER compromised is evaluated by 
comparing the residual UDS activity of the patient derived fibroblast with index cells. For this 
purpose, in a practical UDS based XP-diagnosis, normal fibroblasts have been preloaded with 
latex-beads in the cytoplasm and co-cultured with patient-derived fibroblasts. The 'bead-
labeled-cells' provide an internal standard that can be detected under phase contrast microscopy 
and eliminates sample-to-sample staining variability (15). We tested if this technique is also 
compatible with the EdU assay. First we checked that the latex-beads did not affect the nuclear 
fluorescent intensity. As shown in Figures 4A (top panel) and corresponding histogram 4B, the 
fluorescent intensity in 48BR cells loaded with beads was practically the same as those in cells 
without beads, indicating that the beads do not interfere with the EdU based UDS assay. 
 Modest (XP12BR, Figure 4A middle panel and 4C) as well as severe (XP15BR, Figure 4A 
bottom panel and 4D) UDS-deficient fibroblasts were both easily distinguishable from co-
cultured 48BR fibroblasts by their nuclear fluorescent levels. The UDS measurements with or 
without internal controls were nearly the same (compare Figures 2A, 2C, and 2F with 4B, 4D 
and 4C), suggesting that the prep-to-prep or coverslip-to-coverslip variation in the EdU based 
assay is small; this may be an advantage when applying the EdU assay to experiments that are 
incompatible with the use of an internal standard (e.g. fluorescent-based high throughput 
screening using GE's In-Cell-Analyzer or flow cytometry). 
 
Further optimisation of the EdU assay 
 The EdU based experiments described above are sufficient for routine XP-screening as 
well as many types of NER research; however, further precise experiments such as 
distinguishing between no UDS activity and very low levels, may require higher sensitivity. 
We have attempted to increase the specific EdU uptake as well as to reduce the non-specific 
background. The incorporation of a thymidine analogue into the DNA is dependent on its 
concentration relative to endogenously synthesized thymine nucleotides in the nucleotide pool. 
Fluorodeoxyuridine (FdU) is an inhibitor of thymidylate synthetase, which renders the cell 
dependent on exogenously supplied thymidine or its analogs. We therefore used FdU and a 
longer incubation period (4 h) after UV irradiation. Additionally, we used stringent acid 
extraction with Bouin's fixative to try and reduce the background. As shown in Figure 5, 
although not dramatic, both background (compare white and red bars and their corresponding 
asterisks) and UDS specific EdU uptake (compare black and blue bars) were improved. 
 
 
DISCUSSION 
 Rapid and accurate assessment of UDS levels is indispensable for clinical XP-diagnosis 
as well as NER research. In this report, we have described a novel UDS assay system that 
provides a very simple method for measurement of repair replication activity in human cells. 
Orthodox UDS assay methods have been based on 
3
H-thymidine incorporation (12,15,16). 
Although a variety of alternative reagents have been developed, most XP-diagnosis 
laboratories still measure UDS by autoradiography or direct scintillation counting of 
incorporated 
3
H-thymidine. The biggest disadvantages of using 
3
H-thymidine for UDS assay is 
its time-consuming procedures and the requirement for laboratories designated for radioactive 
work. 
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 The autoradiographic process provides an accurate measurement of UDS activity as each 
silver-grain represents an individual event of nucleotide incorporation into a repair patch. 
However, the experiment is complicated, requiring significant skills, and takes 1-2 weeks to be 
completed; furthermore, counting of silver-grains under the microscope is laborious. An 
alternative procedure uses direct scintillation counting of 
3
H-thymidine incorporation (12). 
This method requires abrogation of S-phase DNA replication. To accomplish this, cells are 
brought into quiescence by serum starvation, and hydroxyurea is needed during the nucleotide 
incorporation period, to block replicative DNA synthesis. This technique significantly reduced 
the time required for the UDS assay, but quantitation of UDS is less accurate.  
 In contrast to the above 
3
H-thymidine based methods, BrdU incorporation assay is faster and a 
convenient option. Indeed, BrdU has been frequently used for cell cycle analysis applications. 
On the other hand, regardless of the type of experiments, denaturation of DNA is needed to 
detect the incorporated BrdU as the anti-BrdU antibody is too big to access the epitope in 
native DNA. DNA denaturation and subsequent immunofluorescence detection sometimes 
generate an ambiguous staining pattern (data not shown, see high S.D. in Figure 1E, 1F). This 
is the biggest disadvantage of the BrdU incorporation assay: nucleotide incorporation into 
repair patches based on DNA repair activity is quite low and difficult to detect. For this reason, 
UDS based on BrdU has not been widely used.  
 The EdU incorporation method was originally developed for complementing known problems 
of S-phase population labeling by 
3
H-thymidine and BrdU (19). In EdU, the methyl group on 
the 5- position of thymidine is replaced by an alkyne group, and this analog is incorporated into 
DNA during replication. Subsequent fluorescent-azide coupling, termed 'click reaction' is rapid, 
sensitive, and specific (19,20): because of this property, the sensitivity and background 
fluorescent signal were both dramatically improved, and hence, EdU can be used for the UDS 
assay. 
 We have presented data demonstrating the usefulness of EdU for the UDS assay. Although the 
sensitivity of the EdU based method is not as high as the autoradiographic technique, we easily 
detected the defect in an XP-D cell-line with ~40% residual UDS activity and based on our 
data we conservatively estimate that we can detect a level of 10-20% of normal UDS. 
 
 The EdU based UDS assay may have an advantage in high-throughput XP-diagnosis using 
flow cytometry. An attempt to use BrdU labeling and flow cytometry for UDS has been 
reported (14). Because of the improved sensitivity of EdU over BrdU, further introduction of 
multicolor labeling (i.e. normal internal control as well as specimen cells, with or without UV 
damage, all labeled with different fluorescent dyes) may provide a rapid and precise 
determination of the relative UDS levels. 
 
 In this report, we have demonstrated that: [1] the accuracy and resolution of the UDS assay 
based on EdU incorporation was comparable to the conventional autoradiographic method: we 
could distinguish between a normal and an XP-deficient primary fibroblast when the cells were 
co-cultured on a single coverslip. [2] The assay was compatible with standard immunostaining 
and latex-bead-labeling, which provide proper internal controls. [3] The time required for the 
assay was dramatically reduced: the entire UDS assay can be completed within half a day from 
the preparation of specimen coverslips. The UDS assay based on EdU could potentially 
become a standard technique in NER research as well as XP-diagnosis. 
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FIGURE LEGENDS 
Figure 1. UV-induced UDS assay in normal human primary fibroblasts. (A) Normal 48BR 
cells were cultured on coverslips, UVC-irradiated at the indicated doses, followed by 
incubation with 10 µM EdU for different time periods, fixation and conjugation of fluorescent-
dye to the incorporated EdU as described in Materials and Methods. The intensity of nuclear 
fluorescence, which is associated with UDS activity, was analysed using a fluorescence 
microscope and image processing software. For each data point, at least 250 nuclei were 
analysed. Points and error-bars indicate means of discrete nuclei fluorescent intensity and 
standard errors, respectively. (B) Typical photos of the EdU assay are shown. 48BR cells were 
UVC irradiated (20J/m
2
, +UV) or mock treated (-UV), followed by 2h incubation with EdU. 
EdU, coupled to Alexa fluor 488-azide; PH, phase contrast. (C-F) UDS performed by 
incorporation of EdU (C, D) or BrdU (E, F) was compared. XP15BR cells are primary 
fibroblasts from an XP-A patient. Cells were UVC irradiated (20J/m
2
), followed by incubation 
with 10µM EdU or 5µM BrdU for 2 h. Bars represent frequencies of the fluorescence levels in 
the indicated classes, with (black) or without (white) UVC irradiation. Asterisks indicate the 
mean values of nuclear fluorescent intensities, which correspond to the UDS levels. ∆ 
represents UDS difference between irradiated and unirradiated samples. 
 
Figure 2. UV-induced EdU incorporation in non-S phase cells is NER repair replication 
specific. (A-G) Levels of UV-UDS in NER-proficient and -deficient cells were examined. 
Primary fibroblasts were cultured on coverslips, UVC irradiated (20J/m
2
), followed by 2h 
incubation with 10µM EdU. Levels of EdU incorporation were analysed as in Figure 1A and 
presented as in Figure 1. (H) UDS assay performed by 
3
H thymidine incorporation. Quiescent 
cells were UVC irradiated at the indicated dose and 
3
H thymidine incorporation was measured 
for 3h after UVC irradiation in the media containing 10mM hydroxyurea. UDS levels were 
normalised and expressed as percentages of the UDS in the normal cells at 10J/m
2
. Mean 
Normal represents the average UDS levels of the 4 different normal cell lines (1BR, 48BR, 
142BR, and 251BR). (I) Typical photos of the EdU incorporation examined in Figure 2A-G 
are shown (2h after 20J/m
2
 UVC irradiation). Arrows indicate non-S phase cells. 48BR, 
normal; 1BR, normal; XP15BR, XP-A; XP20BE, XP-G; XP13BR, XP-C; XP12BR, XP-D; 
CS10LO, CS-B. 
 
Figure 3. EdU assay is compatible with immunostaining. (A) Normal 48BR and XPG-
deficient XP20BE fibroblasts were co-cultured on coverslips, UVC irradiated (20J/m
2
), 
followed by 2h incubation with 10 µM EdU. Fixed cells were then immunostained with rabbit 
anti-XPG antibody (red), followed by conjugation of Alexa fluor 488-azide to incorporated 
EdU (green). (B) UV-induced EdU incorporation in quiescent cells. 48BR cells were UVC 
irradiated (20J/m
2
), followed by 2h incubation with 10 µM EdU. Fixed cells were then 
immunostained with rabbit anti-ki67 antibody (red), followed by conjugation of Alexa fluor 
488-azide to incorporated EdU (green). Triangle, normal arrow, and diamond arrow indicate S-
phase, G0, and G1 (or G2/M), respectively. Detailed experimental conditions are described in 
Materials and Methods. 
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Figure 4. EdU assay in the presence of latex beads. Normal 48BR cells were pre-labeled with 
0.5µm diameter latex beads and co-cultured with indicated XP fibroblasts (no-beads) on 
coverslips. Cells were then UVC-irradiated (20J/m
2
), followed by 2h incubation with 10 µM 
EdU. Coverslips were then processed as in Figure 1. (A) Typical photos are displayed. White 
and red markings, arrows and arrow-heads represent 48BR and indicated XP cells, and non-S 
phase and S-phase cells, respectively. (B-D) Histograms of the UDS assay with the internal 
standard 48BR and (B) 48BR, normal; (C) XP12BR, XP-D; and (D) XP15BR, XP-A. Bars 
represent frequencies as described in Figure 1, with (black, 48BR; blue, XP cell-lines) or 
without (white, 48BR; red, XP cell-lines) UVC irradiation. Asterisks indicate the mean values 
of nuclear fluorescent intensities, which correspond the UDS levels. ∆ represents UDS 
differences with or without UVC irradiation. 
 
Figure 5. Improvement of the sensitivity by FdU supplement, longer incubation, and acid 
extraction. Normal 48BR cells were cultured on coverslips, UVC irradiated (20J/m
2
), followed 
by incubation with 10 µM EdU and 1uM FdU (Sigma) for 4 h. Cells were then fixed as 
indicated in Figure 2. Acid extraction was performed using Bouin's fixative (Sigma) for 30 min, 
followed by extensive washing with PBS. Conjugation of fluorescent-dye and detection of EdU 
signals were identical to the experiments in Figure 2. Bars represent frequencies of the 
fluorescence levels in indicated classes, with (black, identical to Figure 2A; blue, +FdU +4 h 
incubation +acid extraction) or without (white, identical to Figure 2A; red, +FdU +4 h 
incubation +acid extraction) UVC irradiation. Asterisks indicate the mean values of nuclear 
fluorescent intensities. ∆ represents UDS differences with or without UVC irradiation. 
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